Pathway ID | Pathway Description | Count | P-value |
---|---|---|---|
GO:0007229 | integrin-mediated signaling pathway | 3 | 9.56E-04 |
GO:0002283 | neutrophil activation is involved in the immune response | 2 | 2.89E-03 |
GO:0045576 | mast cell activation | 2 | 3.61E-03 |
GO:0046488 | phosphatidylinositol metabolic process | 2 | 5.77E-03 |
GO:0031529 | ruffle organization | 2 | 7.93E-03 |
GO:0006911 | phagocytosis, engulfment | 2 | 8.65E-03 |
GO:0045087 | innate immune response | 3 | 1.11E-02 |
GO:0006958 | complement activation, classical pathway | 2 | 1.15E-02 |
GO:0042102 | positive regulation of T cell proliferation | 2 | 2.86E-02 |
GO:0032587 | ruffle membrane | 2 | 3.06E-02 |
GO:0005581 | collagen trimer | 2 | 3.63E-02 |
GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 2 | 4.54E-02 |
bta04380 | Osteoclast differentiation | 4 | 2.87E-04 |
bta05150 | Staphylococcus aureus infection | 3 | 1.63E-03 |
bta04650 | Natural killer cell-mediated cytotoxicity | 3 | 6.27E-03 |
bta05322 | Systemic lupus erythematosus | 3 | 1.41E-02 |
bta05020 | Prion diseases | 2 | 3.34E-02 |